UA94716C2 - Кальциепептидный компонент для снижения веса тела - Google Patents

Кальциепептидный компонент для снижения веса тела

Info

Publication number
UA94716C2
UA94716C2 UAA200801548A UAA200801548A UA94716C2 UA 94716 C2 UA94716 C2 UA 94716C2 UA A200801548 A UAA200801548 A UA A200801548A UA A200801548 A UAA200801548 A UA A200801548A UA 94716 C2 UA94716 C2 UA 94716C2
Authority
UA
Ukraine
Prior art keywords
calcium
peptide component
body weight
reducing body
peptide
Prior art date
Application number
UAA200801548A
Other languages
English (en)
Ukrainian (uk)
Inventor
Марко Зелль
Дирк Бодэ
Гюнтер Заватцки
Original Assignee
Хумана Мильхунион Эг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Хумана Мильхунион Эг filed Critical Хумана Мильхунион Эг
Publication of UA94716C2 publication Critical patent/UA94716C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
UAA200801548A 2005-07-19 2006-05-31 Кальциепептидный компонент для снижения веса тела UA94716C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005033630A DE102005033630A1 (de) 2005-07-19 2005-07-19 Calcium-Peptid-Komponente

Publications (1)

Publication Number Publication Date
UA94716C2 true UA94716C2 (ru) 2011-06-10

Family

ID=37575596

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200801548A UA94716C2 (ru) 2005-07-19 2006-05-31 Кальциепептидный компонент для снижения веса тела

Country Status (5)

Country Link
EP (1) EP1903895A2 (ru)
DE (1) DE102005033630A1 (ru)
EA (1) EA016259B1 (ru)
UA (1) UA94716C2 (ru)
WO (1) WO2007009529A2 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
DE102006052560B4 (de) * 2006-11-06 2010-01-21 Humana Milchunion Eg Anti-diabetogene Calcium-Peptid-Zusammensetzung
DE102007022694A1 (de) 2007-05-11 2008-11-13 Humana Milchunion Eg Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CA2752800C (en) 2009-02-24 2017-12-05 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
CN103445045A (zh) * 2012-05-30 2013-12-18 孔徐生 一种具有促进钙吸收功能的组合物及其制备方法
CN109805417A (zh) * 2019-03-01 2019-05-28 河南九九一生物科技有限公司 一种能够增加骨密度的保健食品及其加工方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3373544B2 (ja) * 1991-12-05 2003-02-04 明治乳業株式会社 月経困難症を緩和する効果のある、カルシウム利用性に優れた飲食品及び医薬品
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
EP1276392A2 (en) * 2000-04-18 2003-01-22 Société des Produits Nestlé S.A. Nutritional modules
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
GB0100273D0 (en) * 2001-01-08 2001-02-14 Nestle Sa Nutritional composition for a bone condition
US20030165574A1 (en) * 2002-03-01 2003-09-04 Ward Loren Spencer Compositions and methods for treatment of body weight conditions
JP2003048843A (ja) * 2002-07-17 2003-02-21 Meiji Milk Prod Co Ltd 月経困難症の予防及び／又は治療用機能性食品

Also Published As

Publication number Publication date
EA200800205A1 (ru) 2008-08-29
WO2007009529A3 (de) 2007-06-28
DE102005033630A1 (de) 2007-01-25
WO2007009529A2 (de) 2007-01-25
EP1903895A2 (de) 2008-04-02
EA016259B1 (ru) 2012-03-30

Similar Documents

Publication Publication Date Title
UA94716C2 (ru) Кальциепептидный компонент для снижения веса тела
TW200626171A (en) Fixed dosing of HER antibodies
IL187999A0 (en) Compositions for the treatment of persistent infections
EA200702109A1 (ru) Алкинилпирролопиримидины и их применение в качестве ингибиторов hsp90
TW200626068A (en) Active compounds for seed treatment
MXPA04000173A (es) Compuestos basados en peptidos.
AP2007004095A0 (en) Cxcr4 antagonists for the treatment of hiv infection
WO2007150015A3 (en) Method of treatment
WO2007092496A3 (en) 7,9-dihydro-purin-8-one and related analogs as hsp90-inhibitors
WO2011003100A3 (en) Compositions and methods for diagnosing and/or treating influenza infection
WO2011069037A3 (en) Stabilization and storage of biological pharmaceutical compositions
TW200700085A (en) Endoparasiticidal compositions
WO2009085269A3 (en) Use of anti-connexin polynucleotides, peptides or antibodies for the treatment of orthopedic conditions
MA32717B1 (fr) Sels de n-[6-cis- (2.6-dimethylmorpholin-4-yl)pyridin-3-yl)-2-methyl-4'- (trifluoromethoxy)- [1.1'-biphenyl]-3-carboxamide
WO2010012940A3 (fr) Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules
EP4218786A3 (en) Opiorphin for use as analgesic agent
TW200640376A (en) Reduction of digestibility of phosphorus
AU2003251729A8 (en) Use of antibodies against flt-1 for the treatment of osteoporosis
WO2006095173A3 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
RU2007100727A (ru) Керамическая масса
HK1171027A1 (en) Peptides of regulatory or accessory proteins of hiv, compositions and the utilization thereof hiv
GB0520872D0 (en) Onion flavour compounds and use
MX2010000080A (es) Dispositivo para gafas.
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
IL190500A0 (en) Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia